Electrocardiographic changes present in patients diagnosed with metabolic syndrome
Keywords:
Metabolic syndrome, electrocardiogram, cardiovascular riskAbstract
Metabolic syndrome is a disease that currently represents a multiple risk factor for developing cardiovascular disease. This research aimed to determine the electrocardiographic changes present in patients diagnosed with metabolic syndrome (MS).
Downloads
Download data is not yet available.
References
1. Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B, et al. AHA/NHLB1 Scientific statement. Diagnosis and Management of the Metabolic Syndrome. Circulation. 2005; 112 :2735-52.
2. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Gruoup for the study of insulin resistance (EGIR). Diabet Med. 1999; 16: 442-3.
3. Consenso Latinoamericano de la Asociacion Latinoamericana de Diabetes (ALAD). Epidemiología, diagnóstico, control, prevención y tratamiento del síndrome metabólico en adulto. Rev Asoc Latinoam Diab 2010;18:25-44
4. Villalobos SC, Mosquera CP, Tovar CH. Prevalencia del sindrome metabolico en consulta de medicina interna Hospital de San José de Bogota DC. Repert Med Cir2011;20:93-102
5. López-Jaramillo P, Sánchez RA, Díaz M, Cobos L, Bryce A, Parra-Castillo JZ, et al. Grupo de especialistas de America Latina. Latin American Consensus on hypertension in patients with diabetes type 2 and metabolic syndrome. Arq Bras Endocrinol Metabol 2014;58:205-25
6. Riediger ND, Clara I. Prevalence of metabolic syndromein the canadian adult population. CMAJ 2011; 183: E1127-34
7. Pramparo P, Boissonnet C, Schargrodsky H. Evaluation of cardiovascular risk in seven cities in Latin America: the main conclusions of the CARMELA study and substudies. Rev Arg Cardiolog 2011;79(4):377-382
8. Pineda CA. Sindrome metabólico: definición, historia, criterios. Colomb Med. 2008; 39:96-106.
9. Third report of the national colesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood colesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002; 106: 3143-421.
10. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Expert Committee on the diagnosis and classification of diabetes mellitus-American Diabetes Association. Followup report n the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7.
11. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic síndrome. Disponible en: 12. Brollo L, Nogueira M, Do Lago C, Francisco y, Helfenstein F, Camargo A, et al. Asociación del electrocardiograma con diabetes mellitus y síndrome metabólico en nipobrasileños. Arq Bras Cardiol. 2009;92(5):368-372
13. Wilson P, D’Agostino R, Parise H, Sullivan L, Meigs J. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation.2005;112:3066-3072
14. Fuster V, Wayne R y O´Rourke R. Hurst El corazón. Cardiopatía coronaria e hipertensión arterial. 11º edición. McGraw-Hill Interamericana. España. 2007.
15. Ebong I, et al. Electrocardiographic Abnormalities Associated with the Metabolic Syndrome and Its Components: The Multi-Ethnic Study of Atherosclerosis. Metabolic syndrome and related disorders.2012; 2(10):92-97
16. García SI, Morales M, Sanchez Q. Sindrome metabolico y factores de riesgo cardiovascular asociados a la altitud. Enferm Cardiol. 2007-2008; 42-43:15-18
17. Suárez F. ECG. Guía de bolsillo para su interpretación. 1º edición. Editorial Corpus. Argentina. 2004.
18. Salazar F. Electrocardiografía Básica. II edición.Venezuela.1992
19. Kim Hong-Kyu, Kim Chul-Hee, Ko Kwan-Ho, Park Seong-Wook, Park Joong-Yeol, Lee Ki-Up. Variable Association between components of thte metabolic syndrome and electrocardiographic abnormalities in Korean adults. Korean. Korean J Intern Med. 2010;25:174-180
20. Yoon Shin-Eui, Ahn Sung G, Kim Jang-Young, Park Jin-Sun, Shin Joon-Han, Tahk Scung-Jea, et al. Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population. J Korean Med Sci.2011;26:900-905
2. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Gruoup for the study of insulin resistance (EGIR). Diabet Med. 1999; 16: 442-3.
3. Consenso Latinoamericano de la Asociacion Latinoamericana de Diabetes (ALAD). Epidemiología, diagnóstico, control, prevención y tratamiento del síndrome metabólico en adulto. Rev Asoc Latinoam Diab 2010;18:25-44
4. Villalobos SC, Mosquera CP, Tovar CH. Prevalencia del sindrome metabolico en consulta de medicina interna Hospital de San José de Bogota DC. Repert Med Cir2011;20:93-102
5. López-Jaramillo P, Sánchez RA, Díaz M, Cobos L, Bryce A, Parra-Castillo JZ, et al. Grupo de especialistas de America Latina. Latin American Consensus on hypertension in patients with diabetes type 2 and metabolic syndrome. Arq Bras Endocrinol Metabol 2014;58:205-25
6. Riediger ND, Clara I. Prevalence of metabolic syndromein the canadian adult population. CMAJ 2011; 183: E1127-34
7. Pramparo P, Boissonnet C, Schargrodsky H. Evaluation of cardiovascular risk in seven cities in Latin America: the main conclusions of the CARMELA study and substudies. Rev Arg Cardiolog 2011;79(4):377-382
8. Pineda CA. Sindrome metabólico: definición, historia, criterios. Colomb Med. 2008; 39:96-106.
9. Third report of the national colesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood colesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002; 106: 3143-421.
10. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Expert Committee on the diagnosis and classification of diabetes mellitus-American Diabetes Association. Followup report n the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7.
11. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic síndrome. Disponible en: 12. Brollo L, Nogueira M, Do Lago C, Francisco y, Helfenstein F, Camargo A, et al. Asociación del electrocardiograma con diabetes mellitus y síndrome metabólico en nipobrasileños. Arq Bras Cardiol. 2009;92(5):368-372
13. Wilson P, D’Agostino R, Parise H, Sullivan L, Meigs J. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation.2005;112:3066-3072
14. Fuster V, Wayne R y O´Rourke R. Hurst El corazón. Cardiopatía coronaria e hipertensión arterial. 11º edición. McGraw-Hill Interamericana. España. 2007.
15. Ebong I, et al. Electrocardiographic Abnormalities Associated with the Metabolic Syndrome and Its Components: The Multi-Ethnic Study of Atherosclerosis. Metabolic syndrome and related disorders.2012; 2(10):92-97
16. García SI, Morales M, Sanchez Q. Sindrome metabolico y factores de riesgo cardiovascular asociados a la altitud. Enferm Cardiol. 2007-2008; 42-43:15-18
17. Suárez F. ECG. Guía de bolsillo para su interpretación. 1º edición. Editorial Corpus. Argentina. 2004.
18. Salazar F. Electrocardiografía Básica. II edición.Venezuela.1992
19. Kim Hong-Kyu, Kim Chul-Hee, Ko Kwan-Ho, Park Seong-Wook, Park Joong-Yeol, Lee Ki-Up. Variable Association between components of thte metabolic syndrome and electrocardiographic abnormalities in Korean adults. Korean. Korean J Intern Med. 2010;25:174-180
20. Yoon Shin-Eui, Ahn Sung G, Kim Jang-Young, Park Jin-Sun, Shin Joon-Han, Tahk Scung-Jea, et al. Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population. J Korean Med Sci.2011;26:900-905
Published
2018-08-03
How to Cite
Medina Santander, C., Tovar, O., Bohorquez, G., & Meza, I. (2018). Electrocardiographic changes present in patients diagnosed with metabolic syndrome. Revista Venezolana De Salud Pública, 3(2), 35-41. Retrieved from https://revistas.uclave.org/index.php/rvsp/article/view/1444
Issue
Section
Artículos originales
Derechos del/de autor/es a partir del año de publicación
Esta obra está bajo la licencia:
Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
Las opiniones expresadas por los autores no necesariamente reflejan la postura del editor de la publicación ni de la UCLA. Se autoriza la reproducción total o parcial de los textos aquí publicados, siempre y cuando se cite la fuente completa y la dirección electrónica de esta revista. Los autores(as) tienen el derecho de utilizar sus artículos para cualquier propósito siempre y cuando se realice sin fines de lucro. Los autores(as) pueden publicar en internet o cualquier otro medio la versión final aprobada de su trabajo, luego que esta ha sido publicada en esta revista.
